Ayurvedic drug Femicycle as the first line of therapy for stressful menstrual disorders in women of reproductive age
DOI:
https://doi.org/10.15574/HW.2023.166.10Keywords:
women, stress, menstrual cycle disorders, level of perception of stress, level of stress, hormones, Ayurvedic preparations, FemicycleAbstract
Purpose - to evaluate the effectiveness of the use of the Ayurvedic phytocomposition Femicycle for the correction of stressful menstrual disorders (MD) in women of reproductive age.
Materials and methods. Under observation were 209 women aged 18 to 35 years, of which 177 with stressful MD (the Group I) and 32 gynecologically, mentally and somatically healthy women (the Group of the control (GC). All examined patients of the Group I received vitamin - mineral complexes. The Group I included the Main group (n=91), in which women additionally used the Ayurvedic drug Femicycle, 1 capsule twice a day with meals for 6 months. Patients in the Comparison group (n=86) received only vitamin and mineral complexes. The level of perception of stress according to PSS-10 and the level of psychological stress according to PSM-25, the hormonal profile of peripheral blood serum was assessed. MD were assessed before and after the treatment.
Results. The level of perception of stress with the help of PSS-10 in the Group I was 1.57 times higher than in the GC - 34.91±0.56 points vs. 22.21±0.86 points (p<0.01). The level of psychological stress according to PSM-25 in the Group I was 1.28 times higher relative to this indicator in the GC, respectively - 114.61±0.97 points vs. 89.75±3.49 points (p<0.01). Compared to women in the GC, women with stress-induced disorders of the MC had a lower level of luteinizing hormone, increased levels of follicle-stimulating hormone, adrenocorticotropic hormone, thyroid-stimulating hormone against the background of decreased levels of estradiol, free testosterone, androstenedione, dehydroepiandrosterone sulfate and increased levels of cortisol and 17(OH)-progesterone. In patients of the Group I, after stress, the appearance of scanty menstruation was observed in 13.56% of cases, excessive menstruation - in 18.08%, rare menstruation - in 57.06%, amenorrhea - in 12.99% and intermenstrual bleeding - in 11.86%. In women of the Group I, 67.23% of cases had manifestations of dysmenorrhea and 48.59% of premenstrual syndrome vs. 37.50% (OR=3.084; 95% CI: 1.565-7.471) and 25.00% (OR=2.39; 95% CI: 1.209-6.651) individuals of the GC. After 6 months from the start of treatment, in the Main group, compared to the Comparative group, scarce menstruation was recorded 8.47 times less often (OR=2.073; 95% CI: 0.013-0.886), excessive menstruation - by 9.52 times (OR=2.209; 95% CI: 0.012-0.767), rare menstruation - 8.82 times (OR=3.297; 95% CI: 0.024-0.288), amenorrhea - 6.35 times (OR=1.750; 95% CI: 0.018-1.257]), intermenstrual bleeding - 3.70 times (OR=1.680; 95% CI: 0.051-1.254), dysmenorrhea - 1.72 times (OR=3.331; 95% CI: 0.193-0.653]), premenstrual syndrome - 1.71 times (OR=2.343; 95% CI: 0.239-0.880).
Conclusions. Ayurvedic phytocomposition Femicycle is an effective remedy and first choice drug for women of reproductive age in the treatment of stressful MD.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution.
No conflict of interests was declared by the authors.
References
Akiskal KK, Akiskal HS. (2005). The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature. J Affect Disord. 85 (1-2): 231-239. https://doi.org/10.1016/j.jad.2004.08.002; PMid:15780693
Armanini D, Fiore C, Mattarello MJ et al. (2002). History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes. 110 (6): 257-261. https://doi.org/10.1055/s-2002-34587; PMid:12373628
Balan A, Moga MA, Dima L et al. (2021). An Overview on the Conservative Management of Endometriosis from a Naturopathic Perspective: Phytochemicals and Medicinal Plants. Plants (Basel). 10 (3): 587. https://doi.org/10.3390/plants10030587; PMid:33804660 PMCid:PMC8003677
Bhutani KK, Jadhav AN, Kalia V. (2004). Effect of Symplocos racemosa Roxb. on gonadotropin release in immature female rats and ovarian histology. J Ethnopharmacol. 94: 197-200. https://doi.org/10.1016/j.jep.2004.04.022; PMid:15261983
Bormann M, Alt M, Schipper L et al. (2021). Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro. Viruses. 13 (10): 1914. https://doi.org/10.3390/v13101914; PMid:34696344 PMCid:PMC8537626
Cohen S, Kamarck T, Mermelstein R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior. 24: 385-396. https://doi.org/10.2307/2136404; PMid:6668417
Hoffmann KM, Beltrán L, Ziemba PM et al. (2016). Potentiating effect of glabridin from Glycyrrhiza glabra on GABAA receptors. Biochem Biophys Rep. 6: 197-202. https://doi.org/10.1016/j.bbrep.2016.04.007; PMid:29214227 PMCid:PMC5689168
Husain A, Sofi GD, Tajuddin T et al. (2010). Unani system of medicine-introduction and challenges. Med J Islam World Acad Sci. 18: 27-30.
Jadhav M, Menon S, Shailajan S. (2013). Anti-androgenic effect of Symplocos racemosa Roxb. against letrozole induced polycystic ovary using rat model. Journal of Coastal Life Medicine. 1 (4): 309-314.
Jafari Z, Emtiazy M, Sohrabvand F et al. (2019). The effect of Glycyrrhiza glabra L. on Primary Dysmenorrhea compared with Ibuprofen: A Randomized, Triple-Blind Controlled Trial. Iran J Pharm Res. 18 (1): 291-301.
Jena AB, Kanungo N, Nayak V et al. (2021). Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Sci Rep. 11 (1): 2043. https://doi.org/10.1038/s41598-021-81462-7; PMid:33479401 PMCid:PMC7820253
Kageyama Y, Suzuki H, Saruta T. (1994). Role of glucocorticoid in the development of glycyrrhizin-induced hypertension. Clin Exp Hypertens. 16 (6): 761-778. https://doi.org/10.3109/10641969409078024; PMid:7858558
Karimi Jashni H, Kargar Jahromi H, Ghorbani Ranjbary A et al. (2016). Effects of aqueous extract from Asparagus officinalis L. roots on hypothalamic-pituitary-gonadal axis hormone levels and the number of ovarian follicles in adult rats. Int J Reprod Biomed. 14 (2): 75-80. https://doi.org/10.29252/ijrm.14.2.75; PMid:27200420
Lemyre L, Tessier R. (2003). Measuring psychological stress. Concept, model, and measurement instrument in primary care research. Can Fam Physician. 49: 1159-1160, 1166-1168.
Modaresi M, Mahdian B. (2012). The effect of hydroalcoholic extract of Trigonella foenum- Graceum L. on reproductive system in Balb/c. J Herbal Drugs. 2: 261-267.
Nandi PR, Mehta BK, Sengupta D. (2012). Changes in concentration of minerals in follicular fluid of growing follicules. Exp Anim Med Res. 2: 166-169.
Omer N, Rohilla A, Rohilla S, et al. (2012). Nitric Oxide: Role in Human Biology. Int J Pharm Sci Drug Res. 4: 105-109.
Powers CN, Setzer WN. (2015). A molecular docking study of phytochemical estrogen mimics from dietary herbal supplements. In Silico Pharmacol. 3: 4. https://doi.org/10.1186/s40203-015-0008-z; PMid:25878948 PMCid:PMC4397262
Rahaman MM, Rakib A, Mitra S et al. (2020). The Genus Curcuma and Inflammation: Overview of the Pharmacological Perspectives. Plants (Basel). 10 (1): 63. https://doi.org/10.3390/plants10010063; PMid:33396698 PMCid:PMC7824061
Rahmat E, Lee J, Kang Y. (2021). Javanese Turmeric (Curcuma xanthorrhiza Roxb.): Ethnobotany, Phytochemistry, Biotechnology, and Pharmacological Activities. Evid Based Complement Alternat Med: 9960813. https://doi.org/10.1155/2021/9960813; PMid:34194529 PMCid:PMC8214482
Robillard R, Saad M, Edwards J et al. (2020). Social, financial and psychological stress during an emerging pandemic: observations from a population survey in the acute phase of COVID-19. BMJ Open. 10 (12): e043805. https://doi.org/10.1136/bmjopen-2020-043805; PMid:33310814 PMCid:PMC7735085
Salvia S, Varghesea R, Digholkara G et al. (2022). Saraca asoca: A scoping review on the phytoconstituents, bioactives and their therapeutic effects. German J Pharm Biomaterials. 1 (3): 3-13. https://doi.org/10.5530/gjpb.2022.3.11
Sharma PV. (2009). Dravyaguna Vijnana. Varanasi: Chaukhambha Bharati Academy. 2: 671-673.
Singh N, Garg M, Prajapati P et al. (2023). Adaptogenic property of Asparagus racemosus: Future trends and prospects. Heliyon. 9 (4): e14932. https://doi.org/10.1016/j.heliyon.2023.e14932; PMid:37095959 PMCid:PMC10121633
Swarup A, Umadevi K. (1998). Evaluation of Evecare in the treatment of dysmenorrhea and premenstrual syndrome. Obstet Gynaecol Today. 3: 369-372.
Tamir S, Eizenberg M, Somjen D et al. (2000). Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res. 60 (20): 5704-5709.
Tayyaba Rehan S, Imran L, Mansoor H et al. (2022). Effects of SARS-CoV-2 infection and COVID-19 pandemic on menstrual health of women: A systematic review. Health Sci Rep. 5 (6): e881. https://doi.org/10.1002/hsr2.881; PMid:36248348 PMCid:PMC9547349
Uhart M, Wand GS. (2009). Stress, alcohol and drug interaction: an update of human research. Addict Biol. 14 (1): 43-64. https://doi.org/10.1111/j.1369-1600.2008.00131.x; PMid:18855803 PMCid:PMC2654253
Wijaya SH, Nasution AK, Batubara I et al. (2023). Deep Learning Approach for Predicting the Therapeutic Usages of Unani Formulas towards Finding Essential Compounds. Life (Basel). 13 (2): 439. https://doi.org/10.3390/life13020439; PMid:36836796 PMCid:PMC9959740
Yu M, Han K, Nam GE. (2017). The association between mental health problems and menstrual cycle irregularity among adolescent Korean girls. J Affect Disord. 210: 43-48. https://doi.org/10.1016/j.jad.2016.11.036; PMid:28012351
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
